(TheNewswire)
MISSISSAUGA, Ontario – TheNewswire - March 10, 2021 – Sire Bioscience Inc.(CSE:SIRE) (CNSX:SIRE.CN) (OTC:BLLXF)(FSE:BR1B) (“Sire” or the “Company”) announces that, in response to the ongoing global COVID-19pandemic, it will host its annual general and special meeting ofshareholders (the “ Meeting ”) by teleconference only, at 11:00am Pacific Standard Time on Friday, April 9, 2021.
The Company made the decision to hold the Meeting byteleconference after considering Provincial and Federal guidanceregarding public gatherings, and to proactively protect the health andwellbeing of the Company’s shareholders, officers, directors andservice providers that will participate in the Meeting.
The Company encourages its shareholders to vote theircommon shares before the proxy cut-off date of Wednesday, April 7,2021 at 11 am PST and reminds its shareholders that no votes will beaccepted at the Meeting.
Shareholders who wish to attend the Meeting can findthe details to attend below.
Conference Dial-inNumber: 1-888-299-2873 (toll free in Canada)or 1-888-585-9008 (toll-free in the USA)
Conference Room #: 448-444-850
Dial in for any other countries, please contact theCompany at 604.737.2303 prior to the Meeting date for dial inparticulars.
How to Vote:
-
- Registered shareholders of the Company will be able to vote their common sharesonline at www.investorvote.com or bytelephone (1-866-732-VOTE (8683) (Toll Free)). The Registeredshareholders will require their control number which can be found ontheir proxy form that will be mailed out to the Company’sshareholders on or before Friday, March 19, 2021.
- Non-objectingbeneficial (“ NOBO ”) shareholders of theCompany will be able to vote common shares online at www.investorvote.com or by telephone (1-866-734-VOTE (8683) (Toll Free)). TheNOBO holders will require their control number which can be found ontheir voting instruction form.
- Objecting beneficialshareholders of the Company must contact theirbroker directly to obtain their proxy form to vote their commonshares.
About Sire Bioscience Inc.
Sire is headquartered in Mississauga, Ontario, and ismanaged by a group of successful entrepreneurs who have extensiveexperience in the areas of consumer-packaged goods, manufacturing,logistics, and distribution. Sire is a CPG life science companyfocused on the plant-based foods and supplements industry.
For additionalinformation contact:
Sire BioscienceInc.
Brian Polla, CEO
T: 416.669.9392
E: ir@sirebioscience.com
W: sirebioscience.com
Socials: @sirebioscience
The CSE hasneither approved nor disapproved the contents of this news release.Neither the CSE nor its Market Regulator (as that term is defined inthe policies of the CSE) accepts responsibility for the adequacy oraccuracy of this release.
Copyright (c) 2021 TheNewswire - All rights reserved.